 NEW YORK, March 3, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. Brainstorm or the Company NASDAQ: BCLI. Such investors are advised to contact Robert S. Willoughby at or 888-476-6529,... 